Market Tracker

04/26 3:06pm ET

SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of 2:34pm ET
 +0.45 / +1.11%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month-1.63% 3 years-12.11%
3 months-13.12% 5 years+7.67%
1 year-3.39% Since inception+10.58%
Data through 04/26/2018

Quote Details

Previous close$40.46
Open day’s range40.48 – 40.91
Net asset value (NAV)40.49 (04/25/2018)
Daily volume24,523
Average volume (3 months)89,646
Data as of 2:34pm ET, 04/26/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+7.67%+14.29%
Expense Gross exp ratio0.35%1.30%
Risk 5 year sharpe ratio0.510.92
Net assets$360.2M$3.0B
Average market cap$7.8B$10.0B
Average P/E7.522.2
Dividend / Share--0.30%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
VHT Vanguard Health Care Index Fund ETF Shar...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AGN Allergan4.61%
JAZZ Jazz Pharmaceuticals PLC4.26%
ZTS Zoetis Inc4.25%
MRK Merck4.25%
AKRX Akorn Inc4.24%
PRGO Perrigo Company PLC4.22%
NKTR Nektar Therapeutics4.22%
LLY Eli Lilly and Co4.18%
MYL Mylan NV4.17%
PFE Pfizer4.15%